Showing results (301-310 of 415) with videos related to
Sort By:
Pageof 42
Die Pharmazie|October 24, 2015
Analysis of Niemann-Pick C1-like 1 (NPC1L1) genetic polymorphisms and haplotypes in Chinese Han populationXiao-Ya Lou, Chong-Zhen Qin, Mei-Hua Bao, et al.Clinical and Experimental Pharmacology & Physiology|May 16, 2014
Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic efficacy of salvianolate injection in Chinese patients with coronary heart diseaseChao Fang, Xian Ren, Huan Zhou, et al.Journal of Clinical Pharmacology|June 17, 2004
The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteersChuan-Yue Wang, Zhang-Jin Zhang, Wen-Biao Li, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean populationHo-Jin Kang, Im-Sook Song, Ho Jung Shin, et al.The Annals of Pharmacotherapy|May 21, 2010
Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteersYao Chen, Wen-Hui Liu, Bi-Lian Chen, et al.Journal of Ethnopharmacology|May 25, 2011
Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsiaXin-Jian Qiu, Xi Huang, Ze-Qi Chen, et al.Biomed Research International|March 24, 2017
Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male VolunteersYong-Jun Tang, Kai Hu, Wei-Hua Huang, et al.Oncotarget|February 9, 2017
Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancerTao Zhu, Yuan-Feng Gao, Yi-Xin Chen, et al.British Journal of Clinical Pharmacology|March 13, 2003
The distribution and gender difference of CYP3A activity in Chinese subjectsBing Zhu, Zhao-Qian Liu, Guo-Lin Chen, et al.Plos One|March 20, 2014
The association of transporter genes polymorphisms and lung cancer chemotherapy responseYing Wang, Ji-Ye Yin, Xiang-Ping Li, et al.Pageof 42